Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.68 |
| ▸ | F3 | P13726 | 2/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 4/20 | 0.65 |
| ▸ | CA1 | P00915 | 4/20 | 0.65 |
| ▸ | CA2 | P00918 | 4/20 | 0.65 |
| ▸ | CA7 | P43166 | 4/20 | 0.65 |
| ▸ | CA9 | Q16790 | 4/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.65 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.65 |
| ▸ | ESR1 | P03372 | 2/20 | 0.65 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
| ▸ | GLA | P06280 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | CA3 | P07451 | 1/20 | 0.65 |
| ▸ | CA4 | P22748 | 1/20 | 0.65 |
| ▸ | CA6 | P23280 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8996030 | 1.00 | TYR (0.68) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL1226005 | 1.00 | TYR (0.68) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL28645380 | 0.98 | TYR (0.65) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL1226325 | 0.92 | TYR (0.59) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL1226323 | 0.92 | TYR (0.59) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL1359335 | 0.91 | GLA (0.77) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL1359336 | 0.91 | GLA (0.77) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL27623568 | 0.87 | TDP1 (0.72) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL14877958 | 0.85 | APP (0.61) | TYRF3CYP2D6CYP2C9HSD11B1 | |
| SCHEMBL28573627 | 0.85 | APP (0.61) | TYRF3CYP2D6CYP2C9HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250327100-A1 | Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase | BGENE GENETICS (FR) | 2025-10-23 | — | — | US | claimed |
| US-20250171750-A1 | Modified Polyketide Synthase Enzymes and Uses Thereof | BGENE GENETICS (FR) | 2025-05-29 | — | — | US | claimed |
| EP-4560015-A2 | MODIFIED POLYKETIDE SYNTHASE ENZYMES AND USES THEREOF | BGene Genetics (FR) | 2025-05-28 | — | — | EP | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| US-20240309406-A1 | PROCESS FOR PREPARING RASPBERRY KETONE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-09-19 | — | — | US | claimed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4370674-A1 | STRAIN OF PSEUDOMONAS PUTIDA GENETICALLY MODIFIED TO EXPRESS A BENZALACETONE REDUCTASE | BGene Genetics (FR) | 2024-05-22 | — | — | EP | claimed |
| EP-4337767-A1 | BIOSYNTHESIS OF PHENYLPROPANOID COMPOUNDS | BGene Genetics (FR) | 2024-03-20 | — | — | EP | claimed |
| CN-117730147-A | Biosynthesis of phenylpropanoids | B基因遗传学公司 | 2024-03-19 | — | — | CN | claimed |
| EP-1434557-B1 | AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-11-09 | — | — | EP | claimed |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2005-07-07 | — | — | US | claimed |
| EP-1292268-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-02-23 | — | — | EP | claimed |
| EP-1292269-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-02-09 | — | — | EP | claimed |
| WO-1995018606-A9 | CURCUMIN, ANALOGUES OF CURCUMIN AND NOVEL USES THEREOF | — | 1997-05-22 | — | — | WO | claimed |
| EP-0374184-B1 | CELL GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE MEDICINE (US) | 1994-01-12 | — | — | EP | claimed |
| US-5216024-A | Compounds such as methyl p-hydroxypenyllactate, derivatives | BAYLOR COLLEGE OF MEDICINE (US) | 1993-06-01 | — | — | US | claimed |
| WO-1993001824-A1 | COMBINATION THERAPY USING BIOFLAVONOID COMPOUNDS WITH ANTI-CANCER DRUGS | BAYLOR COLLEGE OF MEDICINE (US) | 1993-02-04 | — | — | WO | claimed |
| EP-0374184-A1 | CELL GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES. | BAYLOR COLLEGE MEDICINE (US) | 1990-06-27 | — | — | EP | claimed |
| WO-1989000849-A1 | CELL GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE OF MEDICINE (US) | 1989-02-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | KRT18, TUBB3, DSG1 | TYR 564/4885F3 3351/4885CYP2D6 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.